Intellia Therapeutics, Inc. 4
4 · Intellia Therapeutics, Inc. · Filed Jan 5, 2017
Insider Transaction Report
Form 4
Bell Graeme
EVP, Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2017-01-03+210,000→ 210,000 totalExercise: $13.48Exp: 2027-01-02→ Common Stock (210,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 3, 2017 with respect to 210,000 shares of Common Stock, with 25% vesting on December 12, 2017 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.